PharmaShots | Incisive News in 3 Shots

Subscribe Now

Metastatic RCC

Exelixis Reports Completion of Patient Enrollment in P-III (CONTACT-03) Trial of Cabometyx (cabozantinib) + atezolizumab for Metastatic RCC

Exelixis Reports Completion of Patient Enrollment in P-III (CONTACT-03) Trial of Cabometyx (cabozantinib) + atezolizumab for Metas...

January 6, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us